• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Stada Arzneimittel

Graphic of two hands shaking under a red and purple light
Pharma

Stada snaps up 16 consumer health lines from Orifarm

The deal allows Stada to bolster its consumer health presence in European pharmacies while Orifarm sharpens its focus on pharmaceuticals.
Zoey Becker Jun 24, 2026 11:20am
Asia

Gilead, Tokyo IPO, China's GLP-1 market—Fierce Pharma Asia

Feb 20, 2026 11:12am
Saudi Arabia Saudi Arabia map

Stada sets sights on €85M Saudi Arabia manufacturing hub

Feb 17, 2026 2:28pm
Graphic image of two hands shaking with employeesexecutives on the forearms of each shaking hand

CapVest snaps up German generics maker Stada

Sep 2, 2025 10:12am
IPO initial public offering markets raise financing

German generics maker Stada revives IPO plans: report

Aug 28, 2025 1:00pm
Stada

Stada charts strong first half of 2024 as owners weigh options

Aug 28, 2024 4:25pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings